Literature DB >> 29991708

Developmental and behavioral effects in neonatal and adult mice following prenatal activation of endocannabinoid receptors by capsaicin.

Alex Perchuk1, Sonya M Bierbower1, Ana Canseco-Alba1, Zoila Mora1, Lauren Tyrell1, Neal Joshi1, Norman Schanz1, Georgianna G Gould2, Emmanuel S Onaivi3.   

Abstract

Despite the apparent abundance of ligand-gated transient receptor potential vanilloid type 1 (TRPV1) and possible cross talk between the endocannabinoid and endovanilloid systems in the central nervous system (CNS), it is unclear what role TRPV1 receptor activation in CNS plays in neurobehavioral development. We previously reported that capsaicin or WIN55212-2 induces risk aversion in the plus-maze test, which was dependent on the gender and mouse strain used. In this study, pregnant BALBc mice were administered capsaicin (1.0 or 4.0 mg/kg, i.p.) during the second week of gestation. Developmental effects of prenatal exposure to capsaicin were assessed in neonates, and behavioral effects were assessed in adult offspring. Gender- and dose-specific variations in ultrasonic vocalizations, weight gain, righting reflex, and general activity of the pups were observed. Prenatal exposure to capsaicin altered plus-maze performance, especially with further exogenous capsaicin challenge. Furthermore, dose- and gender-specific effects were evident in the conditioned place preference/aversion paradigm following conditioning with capsaicin in adult animals. The capsaicin-induced aversion in the plus-maze test was enhanced by WIN55212-2 and blocked by pretreatment with vanilloid antagonist capsazepine or the CB1 receptor antagonist rimonabant, demonstrating an interaction between the endocannabinoid and endovanilloid systems in CNS. Taken together, the interaction between the endocannabinoid and endovanilloid signaling systems can be exploited for therapeutic applications in health and disease.

Entities:  

Keywords:  cannabinoids; capsaicin, WIN55212-2; capsazepine; conditioned place preference; plus-maze; prenatal exposure; reward; rimonabant; vanilloids

Mesh:

Substances:

Year:  2018        PMID: 29991708      PMCID: PMC6460370          DOI: 10.1038/s41401-018-0073-z

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  2 in total

1.  Pharmacological characterization of cannabinoids in the elevated plus maze.

Authors:  E S Onaivi; M R Green; B R Martin
Journal:  J Pharmacol Exp Ther       Date:  1990-06       Impact factor: 4.030

2.  Capasaicin induced deafferentation enhances the effect of electrical vagal nerve stimulation on food intake and body mass.

Authors:  J Laskiewicz; G Królczyk; D Zurowski; P Enck; P J Thor
Journal:  J Physiol Pharmacol       Date:  2004-03       Impact factor: 3.011

  2 in total
  3 in total

1.  Cannabis, cannabinoid receptors, and endocannabinoid system: yesterday, today, and tomorrow.

Authors:  Jie Wu
Journal:  Acta Pharmacol Sin       Date:  2019-01-22       Impact factor: 7.169

Review 2.  Depression as a Neuroendocrine Disorder: Emerging Neuropsychopharmacological Approaches beyond Monoamines.

Authors:  Mervin Chávez-Castillo; Victoria Núñez; Manuel Nava; Ángel Ortega; Milagros Rojas; Valmore Bermúdez; Joselyn Rojas-Quintero
Journal:  Adv Pharmacol Sci       Date:  2019-01-03

3.  Capsaicin Causes Vasorelaxation of Rat Aorta through Blocking of L-type Ca2+ Channels and Activation of CB1 Receptors.

Authors:  Felipa Andrade; Cinthia Rangel-Sandoval; Alejandrina Rodríguez-Hernández; Evelyn López-Dyck; Alejandro Elizalde; Adolfo Virgen-Ortiz; Edgar Bonales-Alatorre; Georgina Valencia-Cruz; Enrique Sánchez-Pastor
Journal:  Molecules       Date:  2020-08-30       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.